ABSTRACT
BACKGROUND AND PURPOSE: In a very limited number of cases, acute migrainous aura may mimic acute brain infarction. The aim of this study was to recognize patterns of MR perfusion abnormalities in this presentation. MATERIALS AND METHODS: One thousand eight hundred fifty MR imaging studies performed for the suspicion of acute brain infarction were analyzed retrospectively to detect patients with acute migrainous aura not from stroke. All patients were examined clinically by 2 neurologists and underwent a standard stroke MR imaging protocol, including PWI. Two radiologists reviewed the perfusion maps visually and quantitatively for the presence, distribution, and grade of perfusion abnormalities. RESULTS: Among 1850 MR imaging studies, 20 (1.08%) patients were found to have acute migrainous aura. Hypoperfusion was found in 14/20 patients (70%) with delayed rMTT and TTP, decreased rCBF, and minimal decrease in rCBV. In contrast to the typical pattern in stroke, perfusion abnormalities were not limited to a single vascular territory but extended to >1. Bilateral hypoperfusion was seen in 3/14 cases. In 11/14 cases, hypoperfusion with a posterior predominance was found. TTP and rMTT were the best maps to depict perfusion changes at visual assessment, but also rCBF maps demonstrated significant hypoperfusion in quantitative analysis. In all patients, clinical and imaging follow-up findings were negative for stroke. CONCLUSIONS: Acute migrainous aura is rare but important in the differential diagnosis among patients with the suspicion of acute brain infarction. Atypical stroke perfusion abnormalities can be seen in these patients.
Subject(s)
Magnetic Resonance Angiography , Migraine with Aura/diagnosis , Stroke/diagnosis , Acute Disease , Adolescent , Adult , Cerebral Arteries/pathology , Cerebral Infarction/diagnosis , Cerebrovascular Circulation , Diagnosis, Differential , Female , Humans , Male , Middle Aged , Young AdultABSTRACT
PURPOSE: The aim of this retrospective study was to evaluate peripheral MRA using time-resolved measurements at the femoral as well as the calf level with regard to the presence of unwanted venous overlap. MATERIALS AND METHODS: 150 patients were examined using a 1.5 T MRI unit for a three-step CE MRA approach with three partial injections of contrast agent (0.1 mmol/kg body weight of 1 molar contrast agent). Dynamic time-resolved measurements were used at the femoral as well the calf level. The images were analyzed with respect to the presence and grade of unwanted venous overlap as well as inadequate bolus timing. RESULTS: In all cases, MRA was technically successful. The overall image quality was assessed as excellent in 127 / 150 cases (84.7%), as mildly limited in 21 cases (14%) and as moderately limited, but still diagnostic in 2 cases (1.3%). No obvious overlap was found in 139 of 150 cases (92.7%). Non-diagnostically relevant minor overlap was found in 7 cases (4.6%) and non-diagnostically relevant moderate overlap in 4 cases (2.7%). Relevant venous overlap did not occur. Those 11 cases with minor or moderate overlap occurred at the calf level in 8 cases, at the calf and femoral level in 2 cases and at the femoral level only in one case. In 10 out of 11 cases, peripheral artery occlusive disease was classified as category IV (Fontaine). CONCLUSION: Three-step time-resolved CE MRA with dynamic measurements at the calf as well the femoral level can be considered as a safe and accurate technique for MRA of the lower limbs without significant venous overlap and without risk of inadequate bolus timing. Furthermore, it solves the problem of run time differences.
